Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 2010

View Archived Issues

PBT-434 prevents nigral cell death in models of Parkinson's disease

Piramal Life Sciences describes preclinical pharmacology of new insulin sensitizer P-1738

Studies further characterize HIV integrase inhibitor S/GSK-1349572

Multiple studies describe preclinical profile of antibacterial polypeptide NZ-17074

Helix BioPharma completes GLP toxicology studies of L-DOS-47

Roskamp Institute to begin trials of RCP-006 for treatment of Alzheimer's disease

Genmab and Lundbeck to collaborate on human antibodies for CNS disorders

Merck Frosst discovers novel acyl-CoA desaturase inhibitors

Bayer Schering Pharma discovers vasopressin receptor inhibitors

E.U. concerned member states reach positive agreement for approval of Vimovo

Novel GlyT-1 inhibitors synthesized at sanofi-aventis

ArQule and Daiichi Sankyo expand new kinase inhibitor discovery collaboration

Boehringer Ingelheim discloses new FADK 1 inhibitors

Cell Cure Neurosciences receives investments to develop stem cell treatments

SEPS Pharma patents new antifungal fluconazole derivatives

Tesetaxel receives EMA orphan drug status for gastric cancer

EMA approves Twynsta single pill combination for high blood pressure

Pharmalink obtains FDA orphan drug designation for PL-56

Boehringer Ingelheim discontinues flibanserin development

Antisoma provides update in interim management statement

Alexza receives FDA complete response letter for AZ-004 NDA

Genentech begins phase II vismodegib trial in operable basal cell carcinoma

ESMO and Thomson Reuters collaborate on oncology web portal

Encouraging results reported for phase IIb trial of A-3309 in chronic idiopathic constipation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...